Intercure 

0
44
+C$0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-13.58%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
112.93MRevenue
-15.34MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow INCR.TO. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.
Show more...
CEO
Alexander Rabinovich
Employees
285
Country
Israel
ISIN
IL0011063760

Listings

0 Comments

Share your thoughts

FAQ

What is Intercure stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on Toronto Exchange exchange Intercure stocks are traded under the ticker INCR.TO.
What is Intercure revenue for the last year?
Intercure revenue for the last year amounts to 112.93M CAD.
What is Intercure net income for the last year?
INCR.TO net income for the last year is -15.34M CAD.
How many employees does Intercure have?
As of September 08, 2026, the company has 285 employees.
In which sector is Intercure located?
Intercure operates in the Health & Wellness sector.
When did Intercure complete a stock split?
The last stock split for Intercure was on August 24, 2026 with a ratio of 1:5.
Where is Intercure headquartered?
Intercure is headquartered in Herzliya, Israel.